Gay men who don't have anal sex still at high risk of bacterial STIs
Once-daily raltegravir effective as maintenance therapy
HIV rebound linked to higher baseline level, slower suppression and low-level viraemia
Simultaneous HIV and tuberculosis therapy doesn't cause problems with liver function
Dolutegravir matches or surpasses other regimens for first-line HIV treatment
HCV reinfection is common among HIV-positive gay men in Europe
